stockrowOnconetix, Inc. (ONCO) vs Traws Pharma, Inc. (TRAW)
- Onconetix, Inc. ONCO 6.81 +1,138.18%
- Traws Pharma, Inc. TRAW 0.23 +4.55%
Onconetix, Inc. and Traws Pharma, Inc. are both Biotechnology companies. Onconetix, Inc. and Traws Pharma, Inc. are of similar size ($3.4M and $3.2M). Traws Pharma, Inc. grew revenue faster over the last twelve months: 1,159.3% against −51.3%. Traws Pharma, Inc. has the higher net margin (0.00% vs −1,578.6%) and the higher return on invested capital (0.00% vs −135.4%). Across the 16 metrics below, Traws Pharma, Inc. leads on 11 and Onconetix, Inc. on 5.
Valuation
Profitability
| Metric | ONCO | TRAW | Biotechnology median |
|---|---|---|---|
| Gross margin | 80.38% | 100.00% | 68.51% |
| Operating margin | (2,524.73%) | 0.00% | 0.00% |
| Net margin | (1,578.60%) | 0.00% | 0.00% |
| Free cash flow margin | (1,595.90%) | 0.00% | 0.00% |
| Return on equity | (105.23%) | (336.30%) | (51.96%) |
| Return on assets | (57.37%) | (123.55%) | (46.06%) |
| Return on invested capital | (135.42%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack